Media Contact:
Ihor Andruch
CPRi Communications
201-641-1911 x50
iandruch@cpronline.com
FOR IMMEDIATE
RELEASE
SEPTEMBER IS NATIONAL
CHOLESTEROL EDUCATION MONTH:
TEAFLAVIN® IS NATURAL, GREEN
TEA EXTRACT WITH DOCUMENTED HUMAN
CLINICAL
TRIALS TO LOWER LDL-CHOLESTEROL
Study Published
in Archives of Internal Medicine
Documents Effectiveness of
an Enriched
Tea Extract to Lower LDL-C by 16.4 Percent with No Adverse Effects.
Nashville, Tenn. - September
15, 2004 - For millions
of Americans bordering on dangerously
high cholesterol, learning
the value of a healthy diet
and exercise coupled with the
natural cholesterol-lowering
effect of Teaflavin® (www.teaflavin.com)
- the first tea extract with
clinical trials in humans to
show a cholesterol-lowering
effect from tea - may be one
of the most important lessons
learned during September, National
Cholesterol Education Month.
In July, 2004 U.S. health officials
issued new guidelines recommending
people at very high risk of heart
attack - such as cigarette smokers,
those with existing cardiovascular
disease, or poorly controlled
high blood pressure - lower their
LDL to less than 70 milligrams
per deciliter, from the previous
goal of 100. The guidelines also
recommended drug therapy for
high-risk individuals with LDL
levels of 100 or higher.
"While studies show that cholesterol-lowering
Rx statin medications are extremely
effective, there's also solid
scientific evidence that Teaflavin®,
the all natural, caffeine-free
product now available to consumers
as a 375 milligram daily capsule,
not only lowers LDL-C by 16.4
percent but also raises HDL -
good cholesterol - by 3-4 percent," says
Jim Zhao, Ph.D., a molecular
biologist and Chief Science Officer,
Nashai Biotech, LLC. "The idea
is to do everything natural first."
According to the American Heart
Association, people with total
cholesterol of 240 and above
have double the risk of heart
disease as those who keep their
cholesterol under 200. The study
published in Archives of Internal
Medicine (6/23/03) showed
one reason why people who consume
large amounts of green tea have
a lower risk of heart disease.
Developed by Nashai Biotech,
LLC, Teaflavin®, the concentrated
tea extract, offers a practical
way to get the benefits of tea
without side effects, because
one dose delivers the benefits
of 35 cups of green tea.
The double-blind, randomized,
placebo-controlled, parallel-group
trial involved 240 men and women
age 18 or older on a low fat
diet, with baseline LDL-C (bad
cholesterol) between 130-190.
After 12 weeks, those who received
a 375 milligram daily capsule
containing the tea extract lowered
their LDL-C by 16.4 percent and
raised HDL - good cholesterol
- by 3-4 percent. Teaflavin® represents
the highest concentration of
tea flavonoids on the market
today.
"Since there are few people
who can or will drink that amount
of tea, Teaflavin® is a safe,
non-pharmacologic and cost-effective
option - a first-line therapy
for maintaining healthy cholesterol
levels," concludes Zhao.
For ordering information, visit www.teaflavin.com or call 800-876-4332.
About Nashai Biotech, LLC
Headquartered in Nashville, Tennessee
with offices in Irvine, California
and Shanghai, China, Nashai
Biotech, LLC (www.nashai.com)
produces patented, new generation
formulas and ingredients based
upon compelling scientific
evidence. Nashai's flagship
product is Teaflavin®.
### |